Bluejay Diagnostics, Inc. BJDX
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -4.95% | 5.99% | 5.68% | 2.46% | -1.50% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.07% | 5.07% | -3.53% | -13.58% | -25.75% |
| Operating Income | -9.07% | -5.07% | 3.53% | 13.58% | 25.75% |
| Income Before Tax | -7.95% | 4.83% | 11.27% | 20.24% | 28.39% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -7.95% | 4.83% | 11.27% | 20.24% | 28.39% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -7.95% | 4.83% | 11.27% | 20.24% | 28.39% |
| EBIT | -9.07% | -5.07% | 3.53% | 13.58% | 25.75% |
| EBITDA | -8.87% | -4.99% | 3.55% | 13.56% | 23.93% |
| EPS Basic | 97.43% | 96.02% | 92.24% | 88.94% | -- |
| Normalized Basic EPS | 85.83% | 76.21% | 41.08% | -9.73% | -- |
| EPS Diluted | 97.43% | 96.02% | 92.24% | 88.94% | -- |
| Normalized Diluted EPS | 85.83% | 76.21% | 41.08% | -9.73% | -- |
| Average Basic Shares Outstanding | 558.08% | 730.94% | 900.67% | 2,014.23% | -- |
| Average Diluted Shares Outstanding | 558.08% | 730.94% | 900.67% | 2,014.23% | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |